首页> 外文期刊>The Journal of Urology >Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.
【24h】

Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.

机译:前列腺特异性抗原及其与α2-巨球蛋白和α1-抗胰凝乳蛋白酶复合物的清除机制。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To investigate the rate of elimination of prostate specific antigen (PSA) and its complexes with human alpha2-macroglobulin (alpha2-M) and alpha1-antichymotrypsin (ACT) and to elucidate the role of the alpha2-macroglobulin-receptor/low density lipoprotein receptor-related protein (alpha2-M-R/LRP) in the clearance mechanism. MATERIALS AND METHODS: PSA and complexes of PSA with alpha2-M and ACT were prepared and radiolabeled with [125I]Na (Amersham, Braunschweig, Germany). Radiolabeled proteins were injected into rats and the elimination of radioactivity from circulation was measured by gamma-counting of 20 microL aliquots over time. After 30 minutes different organs were removed and the total radioactivity was counted. The elimination rate and distribution of PSA and PSA-complexes was studied in the absence and presence of an excess of transformed alpha2-M. RESULTS: Radiolabeled PSA is rapidly eliminated from circulation with an initial half-life of 6.4+/-2.1 minutes mainly due to extraction by the liver and kidney. The clearance is slightly inhibited by transformed alpha2-M. PSA-alpha2-M is solely eliminated by the liver with a half-life of 6.7+/-1 minutes. Uptake by the liver is competitively inhibited by transformed alpha2-M. PSA-ACT is eliminated by the liver and kidney with an initial half-life of 3.51+/-1.1 minutes. Transformed alpha2-M failed to inhibit the clearance of PSA-ACT. CONCLUSIONS: Free PSA and PSA-inhibitor complexes are removed from the circulation by different clearance mechanisms. The sites of metabolism of the different forms of PSA are different but include liver and kidney as main organs for uptake. There are indications that alpha2-M-R/LRP is involved in PSA elimination. Thus, factors which modulate the receptor function and expression as well as the concentration of its natural ligands may interfere with the steady state concentrations of different PSA forms in blood.
机译:目的:研究前列腺特异性抗原(PSA)及其与人α2-巨球蛋白(α2-M)和α1-抗胰凝乳蛋白酶(ACT)的复合物的消除率,并阐明α2-巨球蛋白受体/低密度的作用脂蛋白受体相关蛋白(alpha2-MR / LRP)的清除机理。材料与方法:制备PSA以及PSA与alpha2-M和ACT的复合物,并用[125I] Na(Amersham,Braunschweig,Germany)进行放射性标记。将放射性标记的蛋白质注射到大鼠中,并通过随时间推移对20 microL等分试样进行伽玛计数来测量循环中放射性的消除。 30分钟后,取出不同器官并计算总放射性。在不存在和存在过量转化α2-M的情况下研究了PSA和PSA复合物的消除速率和分布。结果:放射性标记的PSA迅速从循环中消除,初始半衰期为6.4 +/- 2.1分钟,主要是由于肝脏和肾脏的提取。该清除被转化的α2-M略微抑制。 PSA-alpha2-M被肝脏完全清除,半衰期为6.7 +/- 1分钟。转化的α2-M竞争性地抑制肝脏的摄取。 PSA-ACT被肝脏和肾脏清除,初始半衰期为3.51 +/- 1.1分钟。转化的alpha2-M无法抑制PSA-ACT的清除。结论:游离PSA和PSA抑制剂复合物通过不同的清除机制从循环中去除。不同形式的PSA的代谢部位不同,但包括肝脏和肾脏作为摄取的主要器官。有迹象表明,α2-M-R/ LRP参与了PSA的消除。因此,调节受体功能和表达及其天然配体浓度的因素可能会干扰血液中不同PSA形式的稳态浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号